Dongguan, China

Ming Luo

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ming Luo

Introduction

Ming Luo is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of RET inhibitors. With a total of 3 patents to his name, his work focuses on innovative solutions for treating RET-related diseases.

Latest Patents

Ming Luo's latest patents include advancements in RET inhibitors and pharmaceutical compositions. These inventions provide compounds that can be utilized in the treatment and prevention of various conditions, including cancer and irritable bowel syndrome. The patents detail a compound having Formula (I) or its various forms, including stereoisomers and prodrugs. The pharmaceutical compositions developed by Luo are designed for the preparation of medicaments aimed at alleviating symptoms associated with RET-related diseases.

Career Highlights

Ming Luo is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and treatment of complex medical conditions. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Ming Luo collaborates with notable colleagues, including Hongming Xie and Jianli Wu. Their combined expertise fosters a productive environment for innovation and discovery in pharmaceutical research.

Conclusion

Ming Luo's contributions to the field of pharmaceuticals, particularly through his patents on RET inhibitors, highlight his role as an influential inventor. His work not only advances medical science but also offers hope for patients suffering from RET-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…